Neisseria gonorrhea and carbapenamase-producing Enterobacteriaceae (CPE) remain the most commonly reported organisms with resistance to critical antibiotics in Australia, according to a report yesterday by the Australian Commission on Safety and Quality in Health Care (the Commission).
The UK Department of Health and Social Care (DHSC) yesterday announced the launch of a £10 million ($13 million) research competition to fund innovative efforts to combat antimicrobial resistance (AMR).
The death toll for a Nipah virus outbreak in India's Kerala state now stands at 10, after at least 12 more people have been diagnosed as having the deadly virus, according to a Reuters report today.
Reuters said an additional nine people are being treated for infections with supportive care. Nipah virus is most commonly spread by fruit bats, and presents with severe, flu-like symptoms.
The United Kingdom's National Institute for Health and Care Excellence (NICE) today issued draft guidance for the treatment of urinary tract infections (UTIs).
In a speech at the annual meeting of the Massachusetts Medical Society on Apr 27, philanthropist and Microsoft cofounder Bill Gates announced the launch of a $12 million Grand Challenge to speed the development of a universal flu vaccine.
The Trump administration yesterday released its budget proposal for the 2019 fiscal year, and it would cut the US Centers for Disease Control and Prevention (CDC) budget by about $900 million, with some increases for the National Institutes of Health (NIH) and the US Food and Drug Administration (FDA).
A series of papers yesterday in Infection Control and Hospital Epidemiology by researchers and clinicians with the Veterans Health Administration (VHA) identifies key knowledge gaps and lays out research agendas to address the spread of drug-resistant pathogens in healthcare settings.
Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Preliminary indications into South Sudan's recent viral hemorrhagic fever outbreak suggest that Rift Valley fever (RVF) may be the cause, the World Health Organization (WHO) Regional Office for Africa said in its latest outbreak and health emergencies update.
A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
